Adenomyosis Treatment Options: Medical, Minimally Invasive, and Surgical

Adenomyosis (endometrial glands/stroma within myometrium) causes heavy menstrual bleeding, dysmenorrhea, chronic pelvic pain, and infertility. Treatment is tailored to symptom severity, age, and fertility desires.

1. Medical Management

  • NSAIDs: First‑line for pain; reduce prostaglandins.
  • Combined oral contraceptives (COCs): Suppress endometrial proliferation; continuous/extended cycling reduces bleeding.
  • Levonorgestrel IUD (52 mg): High local progestin → endometrial atrophy; >90% bleeding reduction; contraceptive.
  • Progestin‑only: Dienogest, norethindrone acetate, depot MPA.
  • GnRH agonists (leuprolide, goserelin) ± add‑back: Hypoestrogenic state → volume reduction; limited to 6–12 mo (bone loss).
  • SPRMs (ulipristal): Not FDA‑approved for adenomyosis; used in some countries.

2. Minimally Invasive / Image‑Guided

  • Uterine artery embolization (UAE): Occludes uterine arteries → infarcts adenomyotic foci; 70–85% symptom relief; fertility preservation possible but ovarian reserve may decline.
  • High‑intensity focused ultrasound (HIFU): Non‑invasive thermal ablation; limited availability; fertility‑sparing.
  • Radiofrequency / microwave ablation: Laparoscopic/transvaginal; emerging.

3. Surgical

  • Adenomyomectomy: Excision of focal/diffuse lesions with uterine reconstruction; technically demanding; recurrence 10–30%. For fertility preservation.
  • Hysterectomy: Definitive cure; laparoscopic/vaginal/robotic. For completed childbearing, refractory symptoms.

Decision Framework

Fertility desire → medical → UAE/HIFU → adenomyomectomy → hysterectomy. Shared decision‑making with gynecologist + interventional radiologist (for UAE).

Tumors - Related Articles